Fulgent Genetics (FLGT) Earnings Date, Estimates & Call Transcripts

$21.41

-0.49 (-2.24%)

(As of 09/6/2024 ET)

Upcoming Earnings Date: Nov. 1Estimated
Actual EPS (Aug. 2): $0.15 Beat By $0.45
Consensus EPS (Aug. 2): -$0.30

FLGT Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

FLGT Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Porter & Company

Why billionaires are wiring money to abandoned towns

A new force is brewing in these forgotten towns that could soon turn Appalachia into one of America’s most valuable economic hubs – the beating heart of a new multi-billion-dollar revolution.

Click here for my exclusive video

Fulgent Genetics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($1.46) EPS
Next Year EPS Consensus Estimate: ($1.72) EPS

FLGT Earnings Date and Information

Fulgent Genetics last posted its earnings results on August 2nd, 2024. The reported $0.15 earnings per share for the quarter, beating the consensus estimate of ($0.30) by $0.45. The company had revenue of $71.03 million for the quarter, compared to the consensus estimate of $69.07 million. Its revenue was up 4.7% compared to the same quarter last year. Fulgent Genetics has generated ($5.57) earnings per share over the last year (($5.57) diluted earnings per share). Earnings for Fulgent Genetics are expected to decrease in the coming year, from ($1.46) to ($1.72) per share. Fulgent Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off prior year's report dates.

Fulgent Genetics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/1/2024 (Estimated)	-	-	-	-	-	-	-
8/2/2024	Q2 2024	($0.30)	$0.15	+$0.45	($0.15)	$69.07 million	$71.03 million
5/3/2024	Q1 2024	($0.58)	($0.38)	+$0.20	($0.31)	$65.74 million	$64.49 million
2/28/2024	Q4 2023	($0.63)	($0.02)	+$0.61	$4.26	$67.14 million	$70.51 million
11/3/2023	Q3 2023	($0.32)	($0.39)	($0.07)	($0.42)	$64.42 million	$84.70 million
8/4/2023	Q2 2023	($0.59)	($0.33)	+$0.26	($0.28)	$62.68 million	$67.85 million
5/5/2023	Q1 2023	($0.68)	($0.47)	+$0.21	($0.42)	$61.95 million	$66.17 million
Get the Latest News and Ratings for FLGT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Fulgent Genetics and its competitors with MarketBeat's FREE daily newsletter.
2/28/2023	Q4 2022	($0.78)	($0.71)	+$0.07	($0.62)	$59.44 million	$67.70 million
11/7/2022	Q3 2022	($0.02)	$0.11	+$0.13	$0.16	$103.70 million	$105.66 million
8/4/2022	Q2 2022	$0.59	$0.59	-	$0.81	$122.70 million	$125.30 million
5/3/2022	Q1 2022	$4.32	$4.93	+$0.61	$4.93	$300.50 million	$320.30 million
2/23/2022	Q4 2021	$2.66	$3.34	+$0.68	$3.34	$191.10 million	$251.67 million
11/9/2021	Q3 2021	$1.30	$3.93	+$2.63	$3.93	$264.00 million	$227.87 million
8/9/2021	Q2 2021	$2.54	$2.47	($0.07)	$2.35	$197.34 million	$153.60 million
5/6/2021	Q1 2021	$5.95	$6.59	+$0.64	$6.50	$326.46 million	$359.43 million
3/3/2021	Q4 2020	$4.36	$6.20	+$1.84	$6.08	$199.38 million	$294.98 million
11/9/2020	Q3	$0.39	$2.08	+$1.69	$1.92	$51.73 million	$101.72 million
8/4/2020	Q2 2020	$0.01	$0.17	+$0.16	$0.20	$14.52 million	$17.27 million
5/4/2020	Q1 2020	$0.02	($0.03)	($0.05)	($0.07)	$7.69 million	$7.75 million
3/10/2020	Q4 2019	$0.04	$0.04	-	$0.01	$9.02 million	$8.39 million
11/4/2019	Q3 2019	$0.01	$0.09	+$0.08	$0.10	$8.48 million	$10.35 million

Fulgent Genetics Earnings - Frequently Asked Questions

When is Fulgent Genetics's earnings date?: Fulgent Genetics has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, November 1st, 2024 based off last year's report dates. Learn more on FLGT's earnings history.
What guidance has Fulgent Genetics issued on next quarter's earnings?: Fulgent Genetics issued an update on its FY 2024 earnings guidance on Friday, August, 2nd. The company provided earnings per share (EPS) guidance of -0.300--0.300 for the period, compared to the consensus estimate of -0.920. The company issued revenue guidance of $280.0 million-$280.0 million, compared to the consensus revenue estimate of $280.2 million.
Did Fulgent Genetics beat their earnings estimates last quarter?: In the previous quarter, Fulgent Genetics (NASDAQ:FLGT) reported $0.15 earnings per share (EPS) to beat the analysts' consensus estimate of ($0.30) by $0.45. Learn more on analysts' earnings estimate vs. FLGT's actual earnings.
How can I listen to Fulgent Genetics's earnings conference call?: The conference call for Fulgent Genetics's latest earnings report can be listened to online. Listen to Conference Call
How can I read Fulgent Genetics's conference call transcript?: The conference call transcript for Fulgent Genetics's latest earnings report can be read online. Read Transcript
How much revenue does Fulgent Genetics generate each year?: Fulgent Genetics (NASDAQ:FLGT) has a recorded annual revenue of $290.71 million.
How much profit does Fulgent Genetics generate each year?: Fulgent Genetics (NASDAQ:FLGT) has a recorded net income of -$167.82 million. FLGT has generated -$5.57 earnings per share over the last four quarters.
What is Fulgent Genetics's EPS forecast for next year?: Fulgent Genetics's earnings are expected to decrease from ($1.46) per share to ($1.72) per share in the next year.